Allergic women have reduced sHLA-G plasma levels at delivery

American Journal of Reproductive Immunology

Volumn 61, Issue 5, 2009, Pages 368-376

  Rizzo, Roberta ^a   Stignani, Marina ^a   Amoudruz, Petra ^b   Nilsson, Caroline ^c   Melchiorri, Loredana ^a   Baricordi, Olavio ^a   Sverremark ekström, Eva ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c SACHS CHILDREN S HOSPITAL   (Sweden)

Author keywords

Delivery; HLA G5; Plasma; sHLA G1

Indexed keywords

ANTIHISTAMINIC AGENT; HLA G ANTIGEN; INTERLEUKIN 10; STEROID;

ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; HUMAN CELL; LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; THIRD TRIMESTER PREGNANCY;

ADULT; FEMALE; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-10; LABOR ONSET; PREGNANCY;

EID: 64249091058     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00703.x     Document Type: Article

References (32)

1. Hunt JS: Stranger in a strange land. Immunol Rev 2006; 213:36-47.
2. Hviid TVF: HLA-G in humAn reproduction: a aspects of genetics, function and pregnancy complication. Human Reprod Update 2006; 12:209-232.
3. Ishitani A, Geraghty DE: Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 1992; 89:3947-3951.
4. Rouas-Freiss N, Gonçalves RM, Menier C, Dausset J, Carosella ED: Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94:11520-11525.
5. CArosella ED, Moreau P, Aractingi S, Rouas-Freiss N: HLA-G: a shield against inflammatory aggression. Trends Immunol 2001; 22:553-555.
6. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, BensussaS A, Le Bouteiller P: Cutting edge: soluble HLA-G1 triggers CD95/ CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164:6100-6104.
7. Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F: Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003; 33:125-134.
8. Riteau B, Rouass-Freiss N, Menier C, Paul P, Dausset J, Carosella ED: HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001; 166:5018-5026.
9. Bainbridge DR, Ellis SA, Sargent IL: HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 2000; 48:17-26.
10. LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED: HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 2004; 101:7064-7069.
11. Gros F, Cabillic F, Toutirais O, Maux AL, Sebti Y, Amiot L: Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells. Eur J Immunol 2008; 38:742-749.
12. Blanco O, Tirado I, Muñoz-Fernández R, Abadía-Molina AC, García-Pacheco JM, Peña J, Olivares EG: Human decidual stromal cells express HLA-G: Effects of cytokines and decidualization. Hum Reprod 2008; 23:144-152.
13. Yie SM, Taylor RN, Librach C: Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005; 193:204-208.
14. Amoudruz P, Minang JT, Sundström Y, Nilsson C, Lilja G, Troye-Blomberg M, Sverremark-Ekström E: Pregnancy, but not the allergic status, influences spontaneous and induced interleukin-1beta (IL-1beta), IL-6, IL-10 and IL-12 responses. Immunology 2006; 119:18-26.
15. Rizzo R, Hviid TV, Stignani M, Balboni A, Grappa MT, Melchiorri L, Baricordi OR: The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 2005; 57:172-181.
16. Rizzo R, Mapp CE, Melchiorri L, Maestrelli P, Visentin A, Ferretti S, Bononi I, Miotto D, Baricordi OR: Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma. J Allergy Clin Immunol 2005; 115:508-513.
17. Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H: Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 2007; 69:143-149.
18. LeFriec G, Laupeze B, Fardel O, Sebti Y, Pangault C, Guilloux V, Beauplet A, Fauchet R, Amiot L: Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum Immunol 2003; 64:752-761.
19. Akkoc T, de Koning PJ, Rückert B, Barlan I, Akdis M, Akdis CA: Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J Allergy Clin Immunol 2008; 121:652-658.
20. Yie SMA, Li LH, Li YM, Librach C: HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 2004; 191:525-529.
21. Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C: Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 2007; 57:277-286.
22. Chaouat G: The TS1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 2007; 29:95-113.
23. Hviid TV, Hylenius S, Rørbye C, Nielsen LG: HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003; 55:63-79.
24. Nilsson C, Linde A, Montgomery SM, Gustafsson L, Näsman P, Blomberg MT, Lilja G: Does early EBV infection protect against IgE sensitization? J Allergy Clin Immunol 2005; 116:438-444.
25. Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX: The 14bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008; 72:335-341.
26. Hviid TV, Christiansen OB: Linkage disquilibrium between human leukocyte antigen (HLA) class II and HLA-G - possible implications for human reproduction and autoimmune disease. Hum Immunol 2005; 66:688-699.
27. Hviid TV, Rizzo R, Melchiorri L, Stignani M, Baricordi OR: Polymorphism in the 5′ upstream regulatory and 3′ untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol 2006; 67:53-62.
28. Yie SM, Li LH, Xiao R, Librach CL: A single base-pair mutation in the 3′-untranslated region of HLA-G mRNA is associated with preeclampsia. Mol Hum Reprod 2008; 14:649-653.
29. Veit TD, Chies JA: Tolerance versus immune response - MicroRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol 2009; 20:229-231.
30. Dong Y, Lieskovska J, Kedrin D, Porcelli S, Mandelboim O, Bushkin Y: Soluble nonclassical HLA generated by the metalloproteinase pathway. Hum Immunol 2003; 64:802-810.
31. Cataldo DD, Bettiol J, Noël A, Bartsch P, Foidart JM, Louis R: Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002; 122:1553-1559.
32. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK: Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006; 11:317-326.